Cargando…

Destruction of Staphylococcus aureus biofilms by combining an antibiotic with subtilisin A or calcium gluconate

In S. aureus biofilms, bacteria are embedded in a matrix of extracellular polymeric substances (EPS) and are highly tolerant to antimicrobial drugs. We thus sought to identify non-antibiotic substances with broad-spectrum activity able to destroy the EPS matrix and enhance the effect of antibiotics...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, JingJing, Madec, Jean-Yves, Bousquet-Mélou, Alain, Haenni, Marisa, Ferran, Aude A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973569/ https://www.ncbi.nlm.nih.gov/pubmed/33737602 http://dx.doi.org/10.1038/s41598-021-85722-4

Ejemplares similares

Comparison of the In vitro Activity of Five Antimicrobial Drugs against Staphylococcus pseudintermedius and Staphylococcus aureus Biofilms
por: Ferran, Aude A., et al.
Publicado: (2016)

Differential Activity of the Combination of Vancomycin and Amikacin on Planktonic vs. Biofilm-Growing Staphylococcus aureus Bacteria in a Hollow Fiber Infection Model
por: Broussou, Diane C., et al.
Publicado: (2018)

Dynamic interactions between cephalexin and macrophages on different Staphylococcus aureus inoculum sizes: a tripartite in vitro model
por: Lallemand, Elodie Anne, et al.
Publicado: (2021)

Comparison of in vitro static and dynamic assays to evaluate the efficacy of an antimicrobial drug combination against Staphylococcus aureus
por: Broussou, Diane C., et al.
Publicado: (2019)

Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in Horses, Cats, and Dogs Over a 5-Year Period in France
por: Haenni, Marisa, et al.
Publicado: (2017)

Genomic Insights into Methicillin-Resistant Staphylococcus aureus spa Type t899 Isolates Belonging to Different Sequence Types
por: Tegegne, Henok Ayalew, et al.
Publicado: (2021)

Phenotypic and genotypic changes of Staphylococcus aureus in the presence of the inappropriate concentration of chlorhexidine gluconate
por: Baseri, Neda, et al.
Publicado: (2022)

Veterinary Medicine Needs New Green Antimicrobial Drugs
por: Toutain, Pierre-Louis, et al.
Publicado: (2016)

Bacterial Species-Specific Activity of a Fluoroquinolone against Two Closely Related Pasteurellaceae with Similar MICs: Differential In Vitro Inoculum Effects and In Vivo Efficacies
por: Lhermie, Guillaume, et al.
Publicado: (2015)

Levers to Improve Antibiotic Treatment of Lambs via Drinking Water in Sheep Fattening Houses: The Example of the Sulfadimethoxine/Trimethoprim Combination
por: Ferran, Aude A., et al.
Publicado: (2020)

The effect of calcium gluconate in the treatment of hyperkalemia
por: Celebi Yamanoglu, Nalan Gokce, et al.
Publicado: (2022)

Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice
por: Vasseur, Maleck V., et al.
Publicado: (2017)

Calcium gluconate: IM calcium deposition: case report
Publicado: (2021)

Emergence of Escherichia coli producing extended-spectrum AmpC β-lactamases (ESAC) in animals
por: Haenni, Marisa, et al.
Publicado: (2014)

Evolution of the Population Structure of Staphylococcus pseudintermedius in France
por: Bergot, Marine, et al.
Publicado: (2018)

Chemical Cardioversion of Atrial Fibrillation with Calcium Gluconate
por: Serhat, A, et al.
Publicado: (2012)

Role of Calcium Gluconate and Iodine in Whooping Cough
por: Misra, R. N.
Publicado: (1941)

Compartment Syndrome Secondary to Calcium Gluconate Extravasation
por: Weimer, Derek S, et al.
Publicado: (2023)

In vitro Degradation of Antimicrobials during Use of Broth Microdilution Method Can Increase the Measured Minimal Inhibitory and Minimal Bactericidal Concentrations
por: Lallemand, Elodie A., et al.
Publicado: (2016)

Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?
por: Concordet, Didier, et al.
Publicado: (2019)

The Selection of Antibiotic- and Bacteriophage-Resistant Pseudomonas aeruginosa Is Prevented by Their Combination
por: Ferran, Aude A., et al.
Publicado: (2022)

Biased computation of probability of target attainment for antimicrobial drugs
por: Toutain, Pierre‐Louis, et al.
Publicado: (2023)

Ultrastructural characteristics of fibrin clots from canine and feline platelet concentrates activated with calcium gluconate or calcium gluconate plus batroxobin
por: Silva, Raúl F, et al.
Publicado: (2013)

Staphylococcus aureus biofilms: recent developments in biofilm dispersal
por: Lister, Jessica L., et al.
Publicado: (2014)

Antimicrobial Treatment of Staphylococcus aureus Biofilms
por: Tuon, Felipe Francisco, et al.
Publicado: (2023)

Authors’ Reply to Castello-Bridoux et al.: “Comment on Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Nicolas: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Coste et al.: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Lechat et al.: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Nicolas: “Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Yu et al.: “Levothyrox(®) New and Old Formulations: Are They Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Calcium Gluconate in Cardiac Failure: Clinical Pharmacology and Therapeutics
por: Rogen, Alfred S.
Publicado: (1940)

Calcium-chelating alizarin and other anthraquinones inhibit biofilm formation and the hemolytic activity of Staphylococcus aureus
por: Lee, Jin-Hyung, et al.
Publicado: (2016)

En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach
por: Toutain, Pierre-Louis, et al.
Publicado: (2017)

Estimated Methicillin-Resistant Staphylococcus aureus Decolonization in Intensive Care Units Associated With Single-Application Chlorhexidine Gluconate or Mupirocin
por: Lofgren, Eric T., et al.
Publicado: (2021)

Deinococcus radiodurans Exopolysaccharide Inhibits Staphylococcus aureus Biofilm Formation
por: Chen, Fengjia, et al.
Publicado: (2021)

agr-Mediated Dispersal of Staphylococcus aureus Biofilms
por: Boles, Blaise R., et al.
Publicado: (2008)

Involvement of Iron in Biofilm Formation by Staphylococcus aureus
por: Lin, Mei-Hui, et al.
Publicado: (2012)

The Role of msa in Staphylococcus aureus Biofilm Formation
por: Sambanthamoorthy, Karthik, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_8s73ua7949vonu6dhql5irc5id